Browsing by Author Langguth, Peter

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
PreviewIssue dateOnline publication dateTitleAuthor(s)
biopharmaceutic_prediction_of-20220623075919234.pdf.jpg20226-Jul-2022Biopharmaceutic Prediction of Oral Absorption from Immediate Release Dosage FormsLangguth, Peter; García Alcalde, Mauricio Andrés
cellular_uptake_and_in_vitro_-20220913202129599.pdf.jpg20154-Oct-2022Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapyPeters, Tanja; Grunewald, Catrin; Blaickner, Matthias; Ziegner, Markus; Schütz, Christian; Iffland, Dorothee; Hampel, Gabriele; Nawroth, Thomas; Langguth, Peter
dithranol_as_novel_coadjuvant-20230127111116015.pdf.jpg202213-Feb-2023Dithranol as novel co-adjuvant for non-invasive dermal vaccinationSohl, Julian; Hartmann, Ann-Kathrin; Hahlbrock, Jennifer; Bartneck, Joschka; Stassen, Michael; Klein, Matthias; Bros, Matthias; Grabbe, Stephan; Marini, Federico; Woods, Kevin; Guezguez, Borhane; Mack, Matthias; Schild, Hansjörg; Muth, Sabine; Melchior, Felix; Probst, Hans Christian; Langguth, Peter; Radsak, Markus P.
efficacy_of_imiquimodbased_tr-20220925171531066.pdf.jpg201419-Oct-2022Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulationStein, Pamela; Gogoll, Karsten; Tenzer, Stefan; Schild, Hansjörg; Stevanovic, Stefan; Langguth, Peter; Radsak, Markus
59555.pdf.jpg202014-Feb-2020Enteric hard capsules for targeting the small intestine : positive correlation between in vitro disintegration and dissolution timesFu, Maoqi; Al-Gousous, Jozef; Blechar, Johannes; Langguth, Peter
formulation_and_characterizat-20220127094614246.pdf.jpg202127-Jan-2022Formulation and Characterization of an Effervescent Hydrogen-Generating TabletRosch, Moritz; Lucas, Kurt; Al-Gousous, Jozef; Pöschl, Ulrich; Langguth, Peter
formulation_and_characterizat-20230706132431904.pdf.jpg202320-Jul-2023Formulation and characterization of colloidal formulations loaded with free amino acids for dermal deliveryLangguth, Peter; Kahsay, Birhanu Nigusse
next_generation__lipid_nanopa-20230424215021548.pdf.jpg20232-Aug-2023Next generation lipid nanoparticles for mRNA deliveryLangguth, Peter; Nogueira, Sara S.
optimized_dithranolimiquimodb-20240205161353824.pdf.jpg202319-Feb-2024Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionHartmann, Ann-Kathrin; Bartneck, Joschka; Pielenhofer, Jonas; Meiser, Sophie Luise; Arnold-Schild, Danielle; Klein, Matthias; Stassen, Michael; Schild, Hansjörg; Muth, Sabine; Probst, Hans Christian; Langguth, Peter; Grabbe, Stephan; Radsak, Markus P.
quality_by_design_qbd_approac-20230216090914073.pdf.jpg20236-Jun-2023Quality by design (QbD) approach for a nanoparticulate imiquimod formulation as an investigational medicinal productPielenhofer, Jonas; Meiser, Sophie Luise; Gogoll, Karsten; Ciciliani, Anna-Maria; Denny, Mark; Klak, Michael; Lang, Berenice M.; Staubach, Petra; Grabbe, Stephan; Schild, Hansjörg; Radsak, Markus P.; Spahn-Langguth, Hilde; Langguth, Peter
transcutaneous_immunization_w-20220620122336479.pdf.jpg201920-Jun-2022Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in miceBialojan, Ariane; Sohl, Julian; Rausch, Johanna; Aranda Lopez, Pamela; Denny, Mark; Langguth, Peter; Hartmann, Ann-Kathrin; Yagita, Hideo; Probst, Hans Christian; Schild, Hansjörg; Radsak, Markus P.
tumorinfiltrating_ccr2_inflam-20240205164246783.pdf.jpg202319-Feb-2024Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapyBartneck, Joschka; Hartmann, Ann-Kathrin; Stein, Lara; Arnold-Schild, Danielle; Klein, Matthias; Stassen, Michael; Marini, Federico; Pielenhofer, Jonas; Meiser, Sophie Luise; Langguth, Peter; Mack, Matthias; Muth, Sabine; Probst, Hans-Christian; Schild, Hansjörg; Radsak, Markus Philipp